Peptide-based cancer vaccines

被引：68

作者：

Melief, CJM ^{[1
]}

Offringa, R ^{[1
]}

Toes, REM ^{[1
]}

Kast, WM ^{[1
]}

机构：

[1] LOYOLA UNIV, CARDINAL BERNADIN CANC CTR, CANC IMMUNOL PROGRAM, MAYWOOD, IL 60153 USA

来源：

CURRENT OPINION IN IMMUNOLOGY | 1996年 / 8卷 / 05期

关键词：

D O I：

10.1016/S0952-7915(96)80081-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The application of molecularly defined vaccines composed of a limited number of tumor-specific T cell epitopes has resulted in protective antitumor T cell immunity in several mouse tumor models. The first encouraging results with such vaccines have been obtained in human beings. The development of the next generation of rationally designed vaccines that are both effective and safe for application in a clinical setting requires comparison of different modes of delivery of tumor-associated T cell epitopes in multiple epitope constructs.

引用

页码：651 / 657

页数：7

共 66 条

[1] Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4(+) and CD8(+)T cell responses
Abrams, SI
Stanziale, SF
Lunin, SD
Zaremba, S
Schlom, J
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (02) : 435 - 443
[2] PEPTIDE-INDUCED T-CELL TOLERANCE TO PREVENT AUTOIMMUNE DIABETES IN A TRANSGENIC MOUSE MODEL
AICHELE, P
KYBURZ, D
OHASHI, PS
ODERMATT, B
ZINKERNAGEL, RM
HENGARTNER, H
PIRCHER, H
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) : 444 - 448
[3] T-CELL PRIMING VERSUS T-CELL TOLERANCE INDUCED BY SYNTHETIC PEPTIDES
AICHELE, P
BRDUSCHARIEM, K
ZINKERNAGEL, RM
HENGARTNER, H
PIRCHER, H
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 261 - 266
[4] INACTIVATED INFLUENZA-VIRUS, WHEN PRESENTED ON DENDRITIC CELLS, ELICITS HUMAN CD8(+) CYTOLYTIC T-CELL RESPONSES
BENDER, A
BUI, LK
FELDMAN, MAV
LARSSON, M
BHARDWAJ, N
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) : 1663 - 1671
[5] ANTIGEN PRESENTATION TO CYTOTOXIC T-LYMPHOCYTES IN-VIVO
BEVAN, MJ
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) : 639 - 641
[6] Human tumor antigens recognized by T lymphocytes
Boon, T
vanderBruggen, P
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) : 725 - 729
[7] Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity
Celluzzi, CM
Mayordomo, JI
Storkus, WJ
Lotze, MT
Falo, LD
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) : 283 - 287
[8] THE MHC CLASS I-RESTRICTED T-CELL RESPONSE TO SENDAI VIRUS-INFECTION IN C57BL/6 MICE - A SINGLE IMMUNODOMINANT EPITOPE ELICITS AN EXTREMELY DIVERSE REPERTOIRE OF T-CELLS
COLE, GA
HOGG, TL
WOODLAND, DL
[J]. INTERNATIONAL IMMUNOLOGY, 1994, 6 (11) : 1767 - 1775
[9] DAHL AM, 1996, IN PRESS J IMMUNOL
[10] IDENTIFICATION OF A GRAFT-VERSUS-HOST DISEASE-ASSOCIATED HUMAN MINOR HISTOCOMPATIBILITY ANTIGEN
DENHAAN, JMM
SHERMAN, NE
BLOKLAND, E
HUCZKO, E
KONING, F
DRIJFHOUT, JW
SKIPPER, J
SHABANOWITZ, J
HUNT, DF
ENGELHARD, VH
GOULMY, E
[J]. SCIENCE, 1995, 268 (5216) : 1476 - 1480

← 1 2 3 4 5 6 7 →